With regulatory bottlenecks significantly delaying the process of characterisation to method validation and release, the European cell therapy community is actively seeking a central hub to collaborate, connect and share insights to drive the future development of cell therapies forward.

Returning to London this September, the 3^rd Cell Therapy Analytical Development Summit Europe is the definitive summit dedicated to defining and refining analytics to ensure the swift progression of highly efficacious products through IND/IMPD and clinical trials.

Uniting pioneering analytical development and quality control experts from Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson & Johnson, GSK, and MHRA, this summit is your one-stop shop to spearhead the future of analytical innovation. 

Discover the full 3-day agenda details here.